Investigator's Brochure (IB) Table
Drugs
| Drug Name Sort descending | Drug Company | IB Date | Risk List Available? |
|---|---|---|---|
| ABT-267, ABT 333, ABT-450 and Ritonavir | AbbVie | June 2017 | |
| Bedaquiline (TMC207) | Janssen Research & Development | October 2019 | |
| Cemiplimab (REGN2810) | Regeneron Pharmaceuticals, Inc. | September 2021 | |
| Cenicriviroc Mesylate CVC (TBR-652) - New - New | Allergan | April 2022 | |
| Dapivirine (Vaginal Ring) | International Partnership For Microbicides | September 2021 | |
| Delamanid (OPC-67683) | Otsuka | June 2021 | |
| Dolutegravir (GSK1349572) - New - New | ViiV Healthcare | October 2022 | |
| Doravirine (MK-1439) and Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (MK-1439A) | Merck | July 2021 | |
| Emtricitabine/Tenofovir Disoproxil Fumarate (Truvada) | Gilead Sciences | December 2016 | YES |
| Glecaprevir (ABT-493) and Pibrentasvir (ABT-530) | AbbVie | December 2018 | |
| GSK1265744 (Cabotegravir) - New - New | ViiV Healthcare | January 2023 | |
| Letermovir | Merck | October 2021 | |
| Pretomanid (PA-824) - New - New | Global Alliance for TB Drug Development (TB Alliance) | January 2023 | |
| Raltegravir (Isentress) | Merck | September 2017 | YES |
| Remdesivir (Veklury) | Gilead Sciences | June 2021 | |
| Rilpivirine (TMC278, Edurant) | Janssen Research & Development | July 2022 | |
| Sofosbuvir/Velapatasvir (Epclusa) | Gilead | July 2016 | |
| Tecovirimat (TPOXX) - New - New | SIGA Technologies, Inc. | December 2022 | |
| Tenofovir Alafenamide/Elvitegravir | CONRAD | July 2019 | |
| Vorinostat (Zolinza) | Merck | August 2013 |
Vaccines
| Vaccine Name Sort descending | Vaccine Company | IB Date | Risk List Available? |
|---|---|---|---|
| MVA.tHIVconsv3 Vaccine | University of Oxford | May 2022 | |
| MVA.tHIVconsv4 Vaccine | University of Oxford | May 2022 | |
| N-803 | Altor BioScience | July 2022 | |
| p24CE1/2 multivalent pDNA Vaccine expressing HIV M Group p24 Gag and p55 gag pDNA with IL-12 pDNA | NCI/NIAID/NIH | November 2017 | |
| PGDM1400 | Beth Israel Deaconess Medical Center | March 2021 | |
| PGDM1400LS (VRC-HIVMAB0112-00AB) - New - New | DAIDS/NIAID/NIH | December 2022 | |
| PGT121 | Beth Israel Deaconess Medical Center | September 2020 | |
| PGT121.414.LS (VRC-HIVMAB0107-00-AB) | VCMP/NIAID/NIH | May 2022 | |
| Recombinant oligomeric gp145 C.6980 Clade C HIV Env protein | NIH/NIAID | August 2017 | |
| RSV 276 | LID/NIAID/NIH | February 2019 | |
| RSV 6120/DeltaNS2/1030s | LID/NIAID/NIH | March 2019 | |
| RSV DeltaNS2-Delta1313-I1314L | LID/NIAID/NIH | February 2019 | |
| RV460 (ALF43) | DAIDS/NIAID/NIH | November 2021 | |
| SAR441236 | Sanofi | August 2021 | |
| Selgantolimod (GS-9688) - New - New | Gilead | January 2023 | |
| Vesatolimod (GS-9620) | Gilead | April 2022 | |
| VRC-HIVMAB060-00-AB (VRC01) | VRC/NIAID | August 2019 | |
| VRC-HIVMAB075-00-AB (VRC07-523LS) | VRC/NIAID/NIH | May 2022 | |
| VRC-HIVMAB080-00-AB (VRC01LS) | VRC/NIAID | December 2019 | |
| VRC-HIVRGP0106-00-VP (HIV-1 Trimer 6931 Vaccine) | VRC/NIAID/NIH | February 2022 |